tert-Butyl 6-(hydroxymethyl)-1H-indazole-1-carboxylate

Catalog No. :
ACUPZX623
CAS No. :
1126424-52-9
Molecular Formula :
C13H16N2O3
Molecular Weight :
248.28

IUPAC Name:tert-butyl 6-(hydroxymethyl)-1H-indazole-1-carboxylate

tert-Butyl 6-(hydroxymethyl)-1H-indazole-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$67.00Login to see priceIn stockInquiry
250mg98%$110.00Login to see priceIn stockInquiry
1g98%$238.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 6-(hydroxymethyl)-1H-indazole-1-carboxylate
IUPAC Nametert-butyl 6-(hydroxymethyl)-1H-indazole-1-carboxylate
MDL No.MFCD11976307
Molecular FormulaC13H16N2O3
Molecular Weight248.28
SMILESOCC1=CC2=C(C=C1)C=NN2C(OC(C)(C)C)=O
InChI KeyJBXIIUJOBLCXRJ-UHFFFAOYSA-N
Synonymtert-Butyl 6-(hydroxymethyl)-1H-indazole-1-carboxylate | 1126424-52-9 | 1-BOC-6-(HYDROXYMETHYL)-1H-INDAZOLE | tert-butyl 6-(hydroxymethyl)indazole-1-carboxylate | 112642-45-2 | SCHEMBL833052 | JBXIIUJOBLCXRJ-UHFFFAOYSA-N | DTXSID001145681 | BVB42452 | MFCD11976307 | AKOS0254
CAS No.1126424-52-9
PubChem CID59490884

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACUPZX623 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFBZO934 route compound structure diagram
    ACFBZO9341126424-50-7 In Stock
  2. Then
  3. ACUPZX623 route product structure diagram
    ACUPZX6231126424-52-9 In Stock
Inquiry

2. ACUPZX623 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUPZX623 route product structure diagram
    ACUPZX6231126424-52-9 In Stock
Inquiry

Comments (0)